1051 related articles for article (PubMed ID: 23077973)
1. Cardiovascular risk of resistant hypertension: dependence on treatment-time regimen of blood pressure-lowering medications.
Ayala DE; Hermida RC; Mojón A; Fernández JR
Chronobiol Int; 2013 Mar; 30(1-2):340-52. PubMed ID: 23077973
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications.
Hermida RC; Ayala DE; Mojón A; Fernández JR
Chronobiol Int; 2013 Mar; 30(1-2):315-27. PubMed ID: 23181712
[TBL] [Abstract][Full Text] [Related]
3. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study.
Hermida RC; Ayala DE; Mojón A; Fernández JR
Chronobiol Int; 2010 Sep; 27(8):1629-51. PubMed ID: 20854139
[TBL] [Abstract][Full Text] [Related]
4. Role of time-of-day of hypertension treatment on the J-shaped relationship between blood pressure and cardiovascular risk.
Hermida RC; Ayala DE; Mojón A; Fernández JR
Chronobiol Int; 2013 Mar; 30(1-2):328-39. PubMed ID: 23181738
[TBL] [Abstract][Full Text] [Related]
5. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.
Hermida RC; Ayala DE; Fernández JR; Mojón A
Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592
[TBL] [Abstract][Full Text] [Related]
6. Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes.
Moyá A; Crespo JJ; Ayala DE; Ríos MT; Pousa L; Callejas PA; Salgado JL; Mojón A; Fernández JR; Hermida RC;
Chronobiol Int; 2013 Mar; 30(1-2):116-31. PubMed ID: 23181613
[TBL] [Abstract][Full Text] [Related]
7. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
Hermida RC; Ayala DE; Mojón A; Fernández JR
Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
[TBL] [Abstract][Full Text] [Related]
8. Treatment-time regimen of hypertension medications significantly affects ambulatory blood pressure and clinical characteristics of patients with resistant hypertension.
Hermida RC; Ríos MT; Crespo JJ; Moyá A; Domínguez-Sardiña M; Otero A; Sánchez JJ; Mojón A; Fernández JR; Ayala DE;
Chronobiol Int; 2013 Mar; 30(1-2):192-206. PubMed ID: 23098160
[TBL] [Abstract][Full Text] [Related]
9. Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease.
Crespo JJ; Piñeiro L; Otero A; Castiñeira C; Ríos MT; Regueiro A; Mojón A; Lorenzo S; Ayala DE; Hermida RC;
Chronobiol Int; 2013 Mar; 30(1-2):159-75. PubMed ID: 23098134
[TBL] [Abstract][Full Text] [Related]
10. Differences between men and women in ambulatory blood pressure thresholds for diagnosis of hypertension based on cardiovascular outcomes.
Hermida RC; Ayala DE; Mojón A; Fontao MJ; Chayán L; Fernández JR
Chronobiol Int; 2013 Mar; 30(1-2):221-32. PubMed ID: 23098170
[TBL] [Abstract][Full Text] [Related]
11. Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients.
Hermida RC; Ayala DE; Crespo JJ; Mojón A; Chayán L; Fontao MJ; Fernández JR
Chronobiol Int; 2013 Mar; 30(1-2):176-91. PubMed ID: 23077974
[TBL] [Abstract][Full Text] [Related]
12. Ambulatory blood pressure monitoring: importance of sampling rate and duration--48 versus 24 hours--on the accurate assessment of cardiovascular risk.
Hermida RC; Ayala DE; Fontao MJ; Mojón A; Fernández JR
Chronobiol Int; 2013 Mar; 30(1-2):55-67. PubMed ID: 23077972
[TBL] [Abstract][Full Text] [Related]
13. Ambulatory blood pressure thresholds for diagnosis of hypertension in patients with and without type 2 diabetes based on cardiovascular outcomes.
Hermida RC; Ayala DE; Mojón A; Fernández JR
Chronobiol Int; 2013 Mar; 30(1-2):132-44. PubMed ID: 23181634
[TBL] [Abstract][Full Text] [Related]
14. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing.
Hermida RC; Ayala DE; Mojón A; Fontao MJ; Fernández JR
Chronobiol Int; 2011 Aug; 28(7):601-10. PubMed ID: 21823969
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
[TBL] [Abstract][Full Text] [Related]
16. Sleep-time blood pressure as a therapeutic target for cardiovascular risk reduction in type 2 diabetes.
Hermida RC; Ayala DE; Mojón A; Fernández JR
Am J Hypertens; 2012 Mar; 25(3):325-34. PubMed ID: 22158066
[TBL] [Abstract][Full Text] [Related]
17. Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk.
Hermida RC; Ayala DE; Mojón A; Fernández JR
J Am Coll Cardiol; 2011 Sep; 58(11):1165-73. PubMed ID: 21884956
[TBL] [Abstract][Full Text] [Related]
18. Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing.
Hermida RC; Ayala DE; Fontao MJ; Mojón A; Fernández JR
Chronobiol Int; 2010 Jul; 27(6):1287-303. PubMed ID: 20653455
[TBL] [Abstract][Full Text] [Related]
19. Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes.
Ayala DE; Moyá A; Crespo JJ; Castiñeira C; Domínguez-Sardiña M; Gomara S; Sineiro E; Mojón A; Fontao MJ; Hermida RC;
Chronobiol Int; 2013 Mar; 30(1-2):99-115. PubMed ID: 23098178
[TBL] [Abstract][Full Text] [Related]
20. Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation.
Hermida RC; Ayala DE; Fernández JR; Mojón A; Smolensky MH; Fabbian F; Portaluppi F
Chronobiol Int; 2013 Mar; 30(1-2):280-314. PubMed ID: 23077971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
